Amy Jeng

Articles by Amy Jeng

45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?

ByAmy Jeng,Cristina Solis-Pomales,Kseniya Roudakova,J. Jamie Alberty-Oller

May 26th 2024

62 The Impact of Genomic Assays on Breast Cancer Systemic Therapy Treatment Decisions in a Mostly Black Patient Population

ByKseniya Roudakova,Cristina Solis-Pomales,Amy Jeng,J. Jaime Alberty-Oller

May 9th 2024

Latest Updated Articles

45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?
May 26th 2024

Trending on CancerNetwork

Azacitidine Plus Ruxolitinib Shows Durable Responses in Myelofibrosis

Defining the Optimal Window for Cytoreductive SABR in Metastatic Kidney Cancer

Building Systems to Catch Liver and Other Cancers in Patients With MASLD

Rusfertide Improves Hematocrit Control vs Placebo in Polycythemia Vera

What Separates a Next-Generation Liver Tumor Board From the Traditional Model?